Universal Security Instruments, Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended September 30, 2014; unaudited. The filing identifies the issuer as Universal Security Instruments, Inc., not Universal Safety Products, Inc. The company markets and distributes safety and security products, primarily manufactured by its 50%-owned Hong Kong joint venture (JV), accounted for under the equity method. Amounts are in U.S. dollars.
Financial performance and position
| Metric | Three months ended September 30, 2014 | Six months ended September 30, 2014 |
|---|---|---|
| Net sales | $2.224 million | $4.738 million |
| Gross profit / margin | $494,000 / 22.2% | $1.105 million / 23.3% |
| Operating loss | $(886,000) | $(1.624) million |
| Equity in JV earnings (loss) | $(78,000) | $(90,000) |
| Net loss | $(954,000), or $(0.41) per share | $(1.697) million, or $(0.73) per share |
For the six months, operating cash flow was positive $738,000, compared with cash used of $1.679 million in the prior-year period. Cash increased to $2.789 million from $2.051 million at March 31, 2014. At September 30, current assets were $7.633 million and current liabilities were $1.071 million. Shareholders’ equity was $20.855 million. The balance sheet reported a $25,000 long-term obligation and no other borrowings; the factoring arrangement provides up to $1.0 million of borrowing availability, secured by receivables and inventory. No interest or income taxes were paid in the six-month period.
Changes versus the prior comparable periods
- Quarterly sales declined 30.4% and six-month sales declined 23.6%. Management attributed the declines mainly to delayed introduction of the new sealed-battery product line, which reduced detector sales.
- Gross margin fell from 25.3% to 22.2% for the quarter and from 25.1% to 23.3% for six months, primarily due to product mix.
- Research and development expense increased 175.1% for the quarter and 90.8% for six months, reflecting consultant costs and timing of independent testing. SG&A rose in dollars and as a percentage of sales, partly due to professional fees and fixed costs against lower revenue.
- Net losses were smaller than in the prior-year periods, principally because the prior year included a noncash tax charge of $2.480 million for the quarter and $2.311 million for six months to establish a valuation allowance against deferred tax assets. The company recorded no income tax expense in 2014.
- The JV’s six-month sales fell 33.2% to $8.521 million, and it reported a $495,000 net loss versus $1.165 million of net income a year earlier. The company’s share of JV results was a $90,000 loss. The JV cited lower sales, reduced gross margins and currency losses.
Outlook, risks and unusual items
Management said cash on hand, availability under the factoring agreement, anticipated future JV distributions and credit facilities should be sufficient for liquidity and working capital. No quantified earnings or revenue guidance was provided. Product-launch delays remain an operating risk; management described new smoke and gas detection products under the IoPhic brand and reported ten patents granted, including six for new technologies and features, with three applications pending.
The company had a full valuation allowance against deferred tax assets of approximately $2.311 million, citing losses, product delays and uncertainty about generating taxable income before certain foreign tax credits expire. It also reported a $25,000 liability for an uncertain tax position, penalties and imputed interest. Management said material litigation losses were not reasonably likely and that legal matters were not expected to have a material adverse effect. A $25,000 warranty reserve was reported for products beyond the manufacturers’ one-year coverage.
Disclosure controls were judged ineffective as of September 30, 2014 because previously identified material weaknesses in internal control over financial reporting had not been remediated. Management stated it was pursuing remediation and believed the reported financial statements were fairly presented. The filing also notes that results for the interim period are not necessarily indicative of full-year results.
Key facts for investors to verify
- Confirm the issuer identity and reporting entity, given the difference between the requested company name and the registrant named in the filing.
- Track timing and commercial results of the sealed-battery product launch, and whether the delays continue to affect sales.
- Review the nature and remediation status of the material weaknesses in internal control.
- Assess liquidity and the factoring facility’s actual availability, borrowing terms and collateral requirements; the filing states a maximum availability of $1.0 million.
- Monitor JV sales, margins, profitability, currency exposure and the timing or likelihood of future distributions.
- Evaluate recoverability and expiration timing of deferred tax assets and foreign tax credits; management’s estimates depend on future taxable income.